Fusion Pharmaceuticals Inc
(FUSN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -33,670 | -94,897 | -66,718 | -49,466 | -24,291 |
| Depreciation Amortization | 361 | 1,345 | 984 | 610 | 273 |
| Income taxes - deferred | -405 | 845 | -2,072 | -1,190 | -494 |
| Accounts receivable | 7 | 54 | 20 | -1 | -28 |
| Accounts payable and accrued liabilities | 445 | -721 | -1,542 | -544 | -704 |
| Other Working Capital | 2,346 | -1,317 | -4,298 | -46 | -3,502 |
| Other Operating Activity | 3,610 | 12,889 | 9,768 | 5,618 | 3,311 |
| Operating Cash Flow | $-27,306 | $-81,802 | $-63,858 | $-45,019 | $-25,435 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,334 | -3,890 | -2,406 | -1,933 | -1,223 |
| Purchase Of Investment | -118,607 | -230,570 | -171,333 | -132,504 | -62,422 |
| Sale Of Investment | 49,570 | 191,697 | 136,218 | 83,590 | 39,117 |
| Investing Cash Flow | $-70,371 | $-42,763 | $-37,521 | $-50,847 | $-24,528 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 14,915 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 49,096 | 146,037 | 88,182 | 87,825 | 63,372 |
| Other Financing Activity | 0 | -4,031 | -4,031 | -4,002 | -3,857 |
| Financing Cash Flow | $64,011 | $142,006 | $84,151 | $83,823 | $59,515 |
| Beginning Cash Position | 62,774 | 45,333 | 45,333 | 45,333 | 45,333 |
| End Cash Position | 29,108 | 62,774 | 28,105 | 33,290 | 54,885 |
| Net Cash Flow | $-33,666 | $17,441 | $-17,228 | $-12,043 | $9,552 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,306 | -81,802 | -63,858 | -45,019 | -25,435 |
| Capital Expenditure | -1,334 | -3,890 | -2,406 | -1,933 | -1,223 |
| Free Cash Flow | -28,640 | -85,692 | -66,264 | -46,952 | -26,658 |